| 发明名称 |
SiRNA against Cbl-b and optionally IL2 und IL12 for use in the treatment of cancer |
| 摘要 |
The invention relates to a method for the immune activation of NK cells by the reduction or inhibition of the Cbl-b function in said cells. This stimulates the congenital immune system and thus permits the therapy of appropriate diseases. |
| 申请公布号 |
AU2011351445(B2) |
申请公布日期 |
2016.10.20 |
| 申请号 |
AU20110351445 |
申请日期 |
2011.12.27 |
| 申请人 |
Apeiron Biologics AG |
发明人 |
Lametschwandtner, Gunther;Loibner, Hans;Schuster, Manfred;Haslinger, Isabella;Seidl, Sandra |
| 分类号 |
A61K38/20;A61P35/00;C12N15/113 |
主分类号 |
A61K38/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
